BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22738171)

  • 1. Effect of homomeric P450-P450 complexes on P450 function.
    Reed JR; Connick JP; Cheng D; Cawley GF; Backes WL
    Biochem J; 2012 Sep; 446(3):489-97. PubMed ID: 22738171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.
    Connick JP; Reed JR; Backes WL
    Drug Metab Dispos; 2018 Mar; 46(3):197-203. PubMed ID: 29233819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions.
    Kelley RW; Cheng D; Backes WL
    Biochemistry; 2006 Dec; 45(51):15807-16. PubMed ID: 17176103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.
    Kelley RW; Reed JR; Backes WL
    Biochemistry; 2005 Feb; 44(7):2632-41. PubMed ID: 15709776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1.
    Connick JP; Reed JR; Cawley GF; Backes WL
    J Biol Chem; 2021; 296():100030. PubMed ID: 33148696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.
    Reed JR; Eyer M; Backes WL
    J Biol Chem; 2010 Mar; 285(12):8942-52. PubMed ID: 20071338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
    Cawley GF; Zhang S; Kelley RW; Backes WL
    Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the contact region responsible for the formation of the homomeric CYP1A2•CYP1A2 complex.
    Saha A; Connick JP; Reed JR; Lott CS; Backes WL
    Biochem J; 2021 Jun; 478(11):2163-2178. PubMed ID: 34032264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
    Backes WL; Batie CJ; Cawley GF
    Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteromeric complex formation between human cytochrome P450 CYP1A1 and heme oxygenase-1.
    Connick JP; Reed JR; Cawley GF; Backes WL
    Biochem J; 2021 Jan; 478(2):377-388. PubMed ID: 33394027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.
    Reed JR; Cawley GF; Backes WL
    Biochemistry; 2013 Jun; 52(23):4003-13. PubMed ID: 23675771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes.
    Voznesensky AI; Schenkman JB
    J Biol Chem; 1994 Jun; 269(22):15724-31. PubMed ID: 8195225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of CYP1 enzymes: Complex formation, membrane localization and function.
    Connick JP; Reed JR; Cawley GF; Saha A; Backes WL
    J Inorg Biochem; 2023 Oct; 247():112325. PubMed ID: 37479567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
    Agrawal V; Huang N; Miller WL
    Pharmacogenet Genomics; 2008 Jul; 18(7):569-76. PubMed ID: 18551037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.
    Reed JR; dela Cruz AL; Lomnicki SM; Backes WL
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):223-30. PubMed ID: 26423927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-dependent competition of different P450 isozymes for limiting NADPH-cytochrome P450 reductase.
    Cawley GF; Batie CJ; Backes WL
    Biochemistry; 1995 Jan; 34(4):1244-7. PubMed ID: 7827074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of P450 2B4 by its association with P450 1A2 revealed by high-pressure spectroscopy.
    Davydov DR; Petushkova NA; Archakov AI; Hoa GH
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1005-12. PubMed ID: 11027582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CYP1A2 localization and lipid microdomain formation as a function of lipid composition.
    Brignac-Huber LM; Reed JR; Eyer MK; Backes WL
    Drug Metab Dispos; 2013 Nov; 41(11):1896-905. PubMed ID: 23963955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.